Biotechs Now in Favor as Funding Opens Up
Venture Capital Surveys Find That 74% Targeting Biotech, Health Care


The venture-capital spigot is flowing again, albeit nowhere near the amounts seen in the boom era of the dot-coms...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $99